Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Fort Wayne
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fort Wayne, IN

Studies commonly pay $75 to $4,500 per completed study

117 clinical trials are currently recruiting participants within 30 miles of Fort Wayne. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

117studies recruiting
2+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Fort Wayne right now

Top 25 of 117 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Endometrial Cancer Phase 3 Interventional 1,123 participants sought
Parkview Research Center ( Site 6008) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06952504)

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Metastatic Non-small Cell Lung Cancer Phase 3 Interventional 734 participants sought
Parkview Packnett Family Cancer Institute — Fort Wayne, Indiana (3.0 mi) · Sponsor: NovoCure GmbH
See eligibility & contact on ClinicalTrials.gov (NCT06216301)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

Neoplasm, Colorectal, Cognitive Impairment N/A Observational 60 participants sought
Parkview Cancer Institute — Fort Wayne, Indiana (3.0 mi) · Sponsor: Joseph McCollom
See eligibility & contact on ClinicalTrials.gov (NCT05014399)

LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)

Degenerative Disc Disease, Lumbar Disc Disease Phase 1, Phase 2 Interventional 40 participants sought
Orthopaedics NorthEast — Fort Wayne, Indiana (3.0 mi) · Sponsor: Locate Bio Pty Ltd
See eligibility & contact on ClinicalTrials.gov (NCT06462729)

Safety and Efficacy of Flaus Electric Flosser on Plaque and Gingivitis Compared to a Manual Toothbrush

Gingivitis, Gingival Bleeding N/A Interventional 80 participants sought
Salus Research, Inc. — Fort Wayne, Indiana (3.0 mi) · Sponsor: Flaus, Inc
See eligibility & contact on ClinicalTrials.gov (NCT07779564)

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic Phase 3 Interventional 735 participants sought
Fort Wayne Medical Oncology and Hematology ( Site 5444) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT05947851)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Fort Wayne, Indiana (3.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Radiation Oncology Associates PC — Fort Wayne, Indiana (3.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

Idiopathic Hypersomnia Phase 3 Interventional 248 participants sought
Fort Wayne Neurological Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Harmony Biosciences Management, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07500090)

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought
Fort Wayne Medical Oncology and Hematology ( Site 0084) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06966700)

An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.

Stomatitis Phase 4 Interventional 100 participants sought
Research Site — Fort Wayne, Indiana (3.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07357597)

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Peripheral Vascular Diseases N/A Observational 5,000 participants sought
St. Joseph Hospital/Dupont Hospital — Fort Wayne, Indiana (3.0 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT04674969)

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Non-small Cell Lung Cancer (NSCLC) Phase 3 Interventional 850 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07361497)

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Large B-cell Lymphoma Phase 2 Interventional 250 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Allogene Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06500273)

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer (CRC) Phase 3 Interventional 600 participants sought
Clinical Study Site — Fort Wayne, Indiana (3.0 mi) · Sponsor: Summit Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07228832)

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Non Small Cell Lung Cancer Phase 3 Interventional 630 participants sought
Fort Wayne Medical Oncology - 1133 — Fort Wayne, Indiana (3.0 mi) · Sponsor: OncoC4, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05671510)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Parkview Research Center at Parkview Regional Medical Center ( Site 0002) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Non Small Cell Lung Cancer Phase 3 Interventional 780 participants sought
Parkview Research Center at Parkview Regional Medical Center ( Site 0089) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06312137)
Actively enrolling

Studies you may be able to join near Fort Wayne

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Fort Wayne

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Salus Research

★ 5.0
1220 Medical Park Dr A, Fort Wayne, IN 46825
(260) 755-1099
"Best of everything! Ten stars out of five!!"
— Bruce Wilder, 5★

Avenues Recovery Center at Fort Wayne

★ 4.9 (957 reviews)
2626 Fairfield Ave, Fort Wayne, IN 46807
(260) 909-8343
"I chose Avenues Ft. Wayne and have not one time felt regret over the decision.<br>The beds here are comfortable.<br>The rooms and facilities are clea…"
— Jonathan Buuck, 5★

Clinical trials in Fort Wayne: what's recruiting

The Fort Wayne area currently has 117 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fort Wayne, the most active research areas are:

  • Cancer & Oncology14 studies
  • Heart & Vascular3 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Fort Wayne, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fort Wayne

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fort Wayne participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fort Wayne pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Fort Wayne?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
What is the difference between a research center and a hospital study in Fort Wayne?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Fort Wayne?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fort Wayne.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fort Wayne typically complete one or two studies per year.

Paid clinical trials near Fort Wayne

Other metros within reach

Elkhart, IN105 Kalamazoo, MI102 South Bend, IN105 Dayton, OH308 Indianapolis, IN931 Toledo, OH212 Lansing, MI172 Ann Arbor, MI1,182

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Fort Wayne Bladder Issues Due To Spinal Cord Injury in Fort Wayne All conditions

More of IN

Indianapolis931 Elkhart105 South Bend105 Evansville71 Lafayette34

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts